May 6, 2024 Sophia Vida
Breaking News

BioStem Technologies Granted Prioritized Examination for Wound Healing Patent

POMPANO BEACH, FLORIDA, May 6, 2024—BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived allografts for advanced wound care, today announced that the United States Patent and Trademark Office (USPTO) has granted the Company’s request for Prioritized Examination for its application for U.S. Patent … Continue reading “BioStem Technologies Granted Prioritized Examination for Wound Healing Patent”